The complex role of vitamin D in autoimmune diseases

Scandinavian Journal of Immunology

Volumn 68, Issue 3, 2008, Pages 261-269

  Szodoray, P ^a   Nakken, B ^a   Gaal, J ^b   Jonsson, R ^c,d   Szegedi, A ^a   Zold, E ^a   Szegedi, G ^a,e   Brun, J G ^d   Gesztelyi, R ^a   Zeher, M ^a   Bodolay, E ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Kenezy Korhaz Rendelointezet   (Hungary)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXY 16,23 DIENE 26,27 HEXAFLUORO 19 NORVITAMIN D3; 20 EPICALCITRIOL; 22 OXACALCITRIOL; CALCITRIOL; COLECALCIFEROL DERIVATIVE; CYCLOSPORIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; RAPAMYCIN; RO 262198; RO 632023; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALITIS; ARTHRITIS; AUTOIMMUNE DISEASE; BIOTECHNOLOGY; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENTERITIS; HOMEOSTASIS; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; LUPUS LIKE SYNDROME; MINERALIZATION; MONOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PATHOGENESIS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; RICKETS; SEASONAL VARIATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; MICE; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 48749115601     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02127.x     Document Type: Review

References (87)

1. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004 89-90: 611 4.
2. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000 223: 230 3.
3. Baldock PA, Thomas GP, Hodge JM et al. Vitamin D action and regulation of bone remodelling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res 2006 21: 1618 26.
4. van Driel M, Koedam M, Burman CJ et al. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 2006 20: 2417 9.
5. 3 levels: the role of renal synthesis and catabolism of vitamin D. J Steroid Biochem Mol Biol 2004 90: 111 3.
6. Morris HA. Vitamin D: a hormone for all seasons - how much is enough? Understanding the new pressures. Clin Biochem Rev 2004 25: 21 32.
7. Cantorna M, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 2004 229: 1136 42.
8. Adorini L. Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis. J Chemother 2001 13: 219 34.
9. Deluca HF, Cantorna M. Vitamin D: its role and uses in immunology. FASEB J 2001 15: 2579 85.
10. Berer A, Stockl J, Majdic O et al. 1,25-dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000 28: 575 83.
11. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 2000 270: 701 8.
12. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000 164: 2405 11.
13. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T Helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008 324: 23 33.
14. + T cells. J Immunol 2002 168: 1181 9.
15. 3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001 145: 351 7.
16. 3-deficient diet. Immunology 1991 73: 466 71.
17. Bikle DD. What is new in vitamin D: 2006-2007. Curr Opin Rheumatol 2007 19: 383 8.
18. 3 as dose-reducing agents for classical immunosuppressants. Transplantation 2000 69: 1932 42.
19. Kuruto-Niwa R, Nakamura M, Takeishi K, Nozawa R. Transcriptional regulation by C/EBP alpha and -beta in the expression of the gene for the MRP14 myeloid calcium binding protein. Cell Struct Funct 1998 23: 109 18.
20. Bamford CR, Sibley WA, Thies C. Seasonal variation of multiple sclerosis exacerbation in Arizona. Neurology 1983 33: 697 701.
21. Embry AF, Snowdon LR, Vieth R. Vitamin D, and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000 48: 271 2.
22. Munger KL, Zhang SM, O'Reilly E et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004 62: 60 5.
23. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Woman's Health Study. Arthritis Rheum 2004 50: 72 7.
24. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001 358: 1500 3.
25. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003 134: 128 32.
26. 3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999 17: 453 6.
27. 3 analogs as potential therapies in transplantation. Curr Opin Invest Drugs 2002 3: 1458 63.
28. Adorini L, Penna G, Giarratana N et al. Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004 89-90: 437 41.
29. 3 in combination with a short induction course of cyclosporin A. Endocrinology 1998 139: 95 102.
30. Jonuleit H, Schmitt G, Schuler J, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic human immature dendritic cells. J Exp Med 2000 192: 1213 22.
31. Aschenbrenner JK, Sollinger HW, Becker BN, Hullett DA. 1,25-OH(2)D(3) alters the transforming growth factor beta signaling pathway in renal tissue. J Surg Res 2001 100: 171 5.
32. 3. Eur J Immunol 2000 30: 498 508.
33. 3: preferential inhibition of Th1 functions. J Nutr 1995 125: 1704S 8S.
34. 3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-b1 and IL-4. J Immunol 1998 160: 5314 9.
35. 3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res 1997 45: 255 67.
36. Bregenholt S, Claesson MH. Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur J Immunol 1998 28: 379 89.
37. Cantorna MT, Hayhes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998 128: 68 72.
38. Tetlow LC, Woolley DE. The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloprotease and prostaglandin E(2) production by cells of the rheumatoid lesion. Arthritis Res 1999 1: 63 70.
39. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 12: 431 40.
40. Uskokovic MR, Norman AW, Manchand PS et al. Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids 2001 66: 463 71.
41. 3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002 51: 1374 6.
42. 3. J Nutr Sci Vitaminol (Tokyo) 1990 36: 21 31.
43. 3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992 12: 143 8.
44. 3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice. J Clin Lab Anal 2000 14: 91 6.
45. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006 5: 114 7.
46. Wei LN. Retinoid receptors and their coregulators. Annu Rev Pharmacol Toxicol 2003 43: 47 72.
47. Barsony J, Marx SJ. Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts. Proc Natl Acad Sci U S A 1988 85: 1223 6.
48. Farach-Carson MC, Nemere I. Membrane receptors for vitamin D steroid hormones: potential new drug targets. Curr Drug Targets 2003 4: 67 76.
49. 3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci U S A 2004 101: 1589 94.
50. Ali MM, Vaidya V. Vitamin D and cancer. J Cancer Res Ther 2007 3: 225 30.
51. Takahashi T, Morikawa K. Vitamin D receptor agonists: opportunities and challenges in drug discovery. Curr Top Med Chem 2006 6: 1303 16.
52. 3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand J Immunol 1993 38: 535 40.
53. 3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cell differentiation, activation and phagocytosis. Immunology 1997 90: 286 93.
54. 3 stimulates phagocytosis but suppresses HLA-DR and CD13 antigen expression in human mononuclear phagocytes. Proc Soc Exp Biol Med 1996 211: 244 50.
55. 3. Diabetes 2002 51: 2119 25.
56. 3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 2001 98: 6800 5.
57. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biophys Res Commun 2000 270: 701 8.
58. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001 167: 1945 53.
59. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci 2003 987: 258 61.
60. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th)- and Th2-inducing cytokines. J Exp Med 2002 195: 603 16.
61. 3 analog with reduced hypercalcemic activity. J Invest Dermatol 2002 119: 1434 42.
62. Verstuyf A, Segaert S, Verlinden L, Bouillon R, Mathieu C. Recent developments in the use of vitamin D analogues. Expert Opin Investig Drugs 2000 9: 443 55.
63. 3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992 4: 506 12.
64. 3 in human macrophages from CAPD patients. Kidney Int 2001 59: 69 75.
65. 3) and its metabolites. Clin Nephrol 1981 16: 119 25.
66. 3 on lymphocytes. FEBS Lett 1986 205: 113 6.
67. 3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998 101: 252 62.
68. 3 inhibits antigen-induced T cell activation. J Immunol 1984 133: 1748 54.
69. 3 receptors in human leukocytes. Science 1983 221: 1181 3.
70. 3 in T lymphocytes. J Immunol 2002 168: 1154 66.
71. 3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur J Immunol 2002 32: 3395 404.
72. 3. Scand J Immunol 1989 30: 55199 208.
73. 3. Cell Immunol 1989 118: 328 36.
74. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for type I (insulin dependent) diabetes mellitus. Diabetologia 1999 42: 51 4.
75. Fronczak CM, Baron AE, Chase HP et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 2003 26: 3237 42.
76. Mathieu C, Laureys J, Eaer M, Bouillon R. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine. Transplant Proc 1994 26: 3128 9.
77. Meehan TP, DeLuca HF. The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch Biochem Biophys 2002 408: 200 4.
78. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000 130: 2648 52.
79. 3 inhibits type II collagen-induced arthritis in rats. FEBS Lett 1994 337: 248 50.
80. Larsson P, Mattsson L, Klareskog L, Johnsson C. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 1998 114: 277 83.
81. Yamauchi Y, Tsunematsu T, Konda S, Hoshino T, Itokawa Y, Hoshizaki H. A double blind trial of alfacalcidol on patients with rheumatoid arthritis (RA). Ryumachi 1989 29: 11 24.
82. 3) for the treatment of psoriasis. Br J Dermatol 1996 134: 1070 8.
83. 3 derivatives in the treatment of psoriasis vulgaris: a preliminary report. Mayo Clin Proc 1993 68: 835 41.
84. 3- report of two cases. J Dermatol 1987 14: 59 62.
85. 3 (calcitriol) in seven children. Pediatr Dermatol 1999 16: 53 8.
86. Kumar S, Davies M, Zakaria Y et al. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J 1994 70: 440 3.
87. Taylor AV, Wise PH. Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 1998 74: 365 6.